C 37 (Stavudine 40 mg)
Pill with imprint C 37 is Orange, Capsule-shape and has been identified as Stavudine 40 mg. It is supplied by Aurobindo Pharma.
Stavudine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Stavudine 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 37
Stavudine
- Imprint
- C 37
- Strength
- 40 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type A potato,
lactose anhydrous,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0047 (Discontinued) | Aurobindo Pharma Limited |
| 68084-0460 (Discontinued) | Amerisource Health Services |
Related images for "C 37"
More about stavudine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Other brands
- Zerit
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.